The receptor for advanced glycation end products (RAGE) and the lung.
AffiliationSchool of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland.
MetadataShow full item record
CitationThe receptor for advanced glycation end products (RAGE) and the lung. 2010, 2010:917108 J. Biomed. Biotechnol.
JournalJournal of biomedicine & biotechnology
AbstractThe receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily of cell surface molecules. As a pattern-recognition receptor capable of binding a diverse range of ligands, it is typically expressed at low levels under normal physiological conditions in the majority of tissues. In contrast, the lung exhibits high basal level expression of RAGE localised primarily in alveolar type I (ATI) cells, suggesting a potentially important role for the receptor in maintaining lung homeostasis. Indeed, disruption of RAGE levels has been implicated in the pathogenesis of a variety of pulmonary disorders including cancer and fibrosis. Furthermore, its soluble isoforms, sRAGE, which act as decoy receptors, have been shown to be a useful marker of ATI cell injury. Whilst RAGE undoubtedly plays an important role in the biology of the lung, it remains unclear as to the exact nature of this contribution under both physiological and pathological conditions.
- The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.
- Authors: Guo WA, Knight PR, Raghavendran K
- Issue date: 2012 Oct
- Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology.
- Authors: Mukherjee TK, Mukhopadhyay S, Hoidal JR
- Issue date: 2008 Aug 31
- Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE).
- Authors: Hanford LE, Enghild JJ, Valnickova Z, Petersen SV, Schaefer LM, Schaefer TM, Reinhart TA, Oury TD
- Issue date: 2004 Nov 26
- A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.
- Authors: Englert JM, Hanford LE, Kaminski N, Tobolewski JM, Tan RJ, Fattman CL, Ramsgaard L, Richards TJ, Loutaev I, Nawroth PP, Kasper M, Bierhaus A, Oury TD
- Issue date: 2008 Mar
- Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.
- Authors: Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA
- Issue date: 2006 May 1